I'm not sure if this has been discussed before (Article dated May 2016)?
Should urologists rethink radical cystectomy (RC) as the best choice for most patients with muscle-invasive bladder cancer (MBIC)?
Yes, says radiation oncologist Timur Mitin, MD, PhD, Oregon Health and Science University, in Portland, who is a staunch proponent of bladder-preserving trimodality therapy (TMT) as an alternative to the gold-standard RC.
No, say Peter Black, MD, and Edmund Chedgy, MBBS, Vancouver Prostate Center, University of British Columbia, Canada, who argue in favor of the gold-standard RC. Both viewpoints were published online May 5 in JAMA Oncology.
www.medscape.com/viewarticle/863338#vp_1